• Mashup Score: 0

    The therapeutic success and widespread approval of genetically engineered T cells for a variety of hematologic malignancies spurred the development of synthetic cell-based immunotherapies for CNS lymphoma, primary brain tumors, and a growing spectrum of nononcologic disease conditions of the nervous system. Chimeric antigen receptor effector T cells bear the potential to deplete target cells with…

    Tweet Tweets with this article
    • Review: Synthetic Cell-Based Immunotherapies for Neurologic Diseases https://t.co/FU6aoeNcPF #NeuroTwitter #Neurology https://t.co/zYTQk4oMwf

  • Mashup Score: 3

    Acknowledgment to ReviewersResearch Articles Open Access Treatment With Erythropoietin for Patients With Optic NeuritisLong-term Follow-up Sebastian Küchlin, Gabriele Ihorst, Birgit Grotejohann, Flemming Beisse, Sven P. Heinrich, Philipp Albrecht, Judith Ungewiss, Michael Wörner, Martin J. Hug, Sebastian Wolf, Ricarda Diem, Wolf A. Lagrèze …

    Tweet Tweets with this article
    • The July 2023 issue of Neurology: Neuroimmunology & Neuroinflammation is now online! All articles are free to read: https://t.co/S2yq724zol #NeuroTwitter https://t.co/2feftuorwl

  • Mashup Score: 2

    Background and Objective Despite accumulating evidence of intrathecal inflammation in patients with primary progressive multiple sclerosis (PPMS), immunomodulatory and suppressive treatment strategies have proven unsuccessful. With this study, we investigated the involvement of CD20+ T cells and the effect of dimethyl fumarate on CD20+ T cells in PPMS. Methods The main outcomes in this…

    Tweet Tweets with this article
    • This study investigated the involvement of CD20+ T cells and the effect of dimethyl fumarate on CD20+ T cells in primary progressive multiple sclerosis. Read the open access article: https://t.co/s8L9LI7Pwk #NeuroTwitter #MS https://t.co/5Yy0MOYLM7

  • Mashup Score: 0

    Background and Objectives In the multiple sclerosis (MS) brain, chronic active lesions can be detected using MRI- and PET-based methods. In this study, we investigated whether the frequency of TSPO-PET–detectable chronic active lesions associates with disease progression measured using the Expanded Disability Status Scale (EDSS) at 5-year follow-up. Methods Chronic lesion–associated innate…

    Tweet Tweets with this article
    • Study results show that single TSPO-PET–based in vivo lesion phenotyping of chronic multiple sclerosis (MS) lesions provides a strong predictor for #MS disease progression. Learn more: https://t.co/GkI17BjNos #NeuroTwitter https://t.co/SQ1dmSrS6o

  • Mashup Score: 0

    Objective To determine whether the frequency of paraneoplastic or autoimmune encephalitis antibodies examined in a referral center changed during the COVID-19 pandemic. Methods The number of patients who tested positive for neuronal or glial (neural) antibodies during pre–COVID-19 (2017–2019) and COVID-19 (2020–2021) periods was compared. The techniques used for antibody testing did not change…

    Tweet Tweets with this article
    • Frequency and Referral Patterns of Neural Antibody Studies During the #COVID-19 Pandemic: Experience From an Autoimmune Neurology Center https://t.co/za6n7BMIr4 #NeuroTwitter https://t.co/mCcOTF5Zc9

  • Mashup Score: 0

    Objectives Vaccine-induced immune thrombotic thrombocytopenia (VITT), a recently described entity characterized by thrombosis at unusual locations such as cerebral venous sinus and splanchnic vein, has been rarely described after adenoviral-encoded COVID-19 vaccines. In this study, we report the immunohistological correlates in 3 fatal cases of cerebral venous thrombosis related to VITT analyzed…

    Tweet Tweets with this article
    • This study reports the immunohistological correlates in 3 fatal cases of cerebral venous thrombosis related to vaccine-induced immune thrombotic thrombocytopenia after adenoviral COVID-19 vaccination, analyzed at an academic medical center: https://t.co/mJeJLAP4mF #NeuroTwitter https://t.co/Wefgjwv91x

  • Mashup Score: 2

    Objectives Autoimmune encephalitis (AE) with antibodies against LGI1 and IgLON5 are clinically distinctive but share some particularities such as a strong association with specific human leukocyte antigen (HLA) class II alleles. Methods We clinically describe a patient with double positivity for LGI1 and IgLON5 antibodies. In addition, we conducted specific immunodepletion with the patient’s…

    Tweet Tweets with this article
    • Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes https://t.co/iT8FWlkzGP #NeuroTwitter https://t.co/kyVjD7XbXm